The Antibody Drug Conjugates Market is driven by growing demand for targeted cancer therapeutics
The antibody drug conjugates market consists of innovative targeted cancer therapies designed to deliver highly potent anti-cancer drugs specifically to tumor cells. These conjugates link monoclonal antibodies that bind to antigens present on certain cancer cell types to cytotoxic agents or chemotherapy drugs. By combining the unique targeting capabilities of monoclonal antibodies with the...
0 Comments
0 Shares
French (Français)
Spanish (Español)
Arabic
Portuguese (Português)
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Italiano
Romaian (Română)
Português (Brasil)
Greek (Ελληνικά)
Russian (русский)